FDA commissioner Gottlieb resigns

Clicks: 363
ID: 71149
2019
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
No abstract available. Article truncated after 150 words. Food and Drug Administration (FDA) Commissioner, Scott Gottlieb, has resigned after about 2 years (1). Gottlieb was a controversial appointee by the Trump administration due to his ties to the pharmaceutical industry. However, he stood out in the anti-regulatory Trump administration, where some officials such as Scott Pruitt, the former head of the Environmental Protection Agency, appeared intent on reducing the clout of the departments and agencies they headed. For nearly two years, Gottlieb has avidly promoted the FDA, inserting the agency into important health issues and sometimes taking on industries regulated by the agency. Under Gottlieb’s leadership the FDA has made sweeping moves to lower smoking and vaping amongst minors. Gottlieb’s departure could throw into question other controversial tobacco initiatives he championed that have not yet emerged from the FDA, including proposals to ban menthol cigarettes and to reduce nicotine levels in cigarettes. In his resignation letter to Health …
Reference Key
ra2019fdasouthwest Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors RA, Robbins;
Journal southwest journal of pulmonary and critical care
Year 2019
DOI
DOI not found
URL
http://www.swjpcc.com/news/2019/3/7/fda-commissioner-gottlieb-resigns.html
Keywords
Ecology Medicine (General) Language. Linguistic theory. Comparative grammar Medical emergencies. Critical care. Intensive care. First aid physics renewable energy sources general works arctic medicine. tropical medicine philology. linguistics special aspects of education philosophy (general) arts in general judaism

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.